Related Experiment Videos
An unusual factor-X inhibitor in leprosy
American Journal of Hematology
|January 1, 1980
Summary
Two Hansen disease cases revealed a lupus-like inhibitor affecting coagulation factor X activation. Assays showed depressed factor X activity in one system but normal levels in three others, highlighting diagnostic challenges.
Area of Science:
- Hematology
- Immunology
- Infectious Diseases
Background:
- Hansen disease, also known as leprosy, is a chronic infectious disease caused by Mycobacterium leprae.
- Autoimmune phenomena, including inhibitors of coagulation factors, can occur in infectious diseases.
- Coagulation factor X plays a critical role in the blood coagulation cascade.
Observation:
- Two patients with Hansen disease presented with a lupus-like anticoagulant.
- This inhibitor was specifically directed against the activation of coagulation factor X.
- Factor X activity was markedly depressed in one specific assay system.
Findings:
- Despite significant depression in one assay, factor X activity measured by three alternative assay systems yielded normal results.
- This discrepancy suggests assay-dependent sensitivity to the inhibitor.
- The inhibitor's presence indicates a complex interplay between infection and the coagulation system.
Implications:
- These findings highlight the potential for diagnostic discrepancies in coagulation factor assays when specific inhibitors are present.
- Understanding such inhibitors is crucial for accurate diagnosis and management of bleeding or thrombotic risks in patients with Hansen disease.
- Further research is needed to characterize the inhibitor and its precise mechanism of action.